Identification and functional validation of caldesmon as a potential gastric cancer metastasis-associated protein

Journal of Proteome Research

Volumn 12, Issue 2, 2013, Pages 980-990

  Hou, Qian ^a   Tan, Hwee Tong ^a   Lim, Kiat Hon ^b   Lim, Teck Kwang ^a   Khoo, Avery ^b   Tan, Iain B H ^c   Yeoh, Khay Guan ^a   Chung, Maxey C M ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

biomarker; caldesmon; gastric cancer; iTRAQ; metastasis

Indexed keywords

CALDESMON;

ARTICLE; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEOMICS; RECEPTOR UPREGULATION; STOMACH CANCER; VALIDATION PROCESS; WESTERN BLOTTING;

BLOTTING, WESTERN; CALMODULIN-BINDING PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; RNA, SMALL INTERFERING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873346753     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3010259     Document Type: Article

References (38)

1. Garcia, M.; Jemal, A.; Ward, E. M.; Center, M. M.; Hao, Y.; Siegel, R. L.; Thun, M. J. Global Cancer Facts and Figures; American Cancer Society: Atlanta, GA, 2007; pp 18-19.
2. Brenner, H.; Rothenbacher, D.; Arndt, V. Cancer Epidemiol., Methods Mol. Biol. 2009, 472 (II) 467-477
3. Tsukuma, H.; Oshima, A.; Nakahara, H.; Morii, T. Natural history of early gastric cancer: a non-concurrent, long term, follow up study Gut 2000, 47, 618-621
4. Leung, W. K.; Wu, M. S.; Kakugawa, Y.; Kim, J. J.; Yeoh, K. G.; Goh, K. L.; Wu, K. C.; Wu, D. C.; Sollano, J.; Kachintorn, U.; Gotoda, T.; Lin, J. T.; You, W. C.; Ng, E. K.; Sung, J. J. Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice Lancet Oncol. 2008, 9 (3) 279-287
5. Norton, J. A. Surgery: basic science and clinical evidence Springer 2001, 1628
6. Lam, K. W.; Lo, S. C. Discovery of diagnostic serum biomarkers of gastric cancer using proteomics Proteomics Clin. Appl. 2008, 2 (2) 219-228
7. Cho, W. C. S. Contribution of oncoproteomics to cancer biomarker discovery Mol. Cancer 2007, 6, 25
8. Petricoin, E. F.; Zoon, K. C.; Kohn, E. C.; Barrett, J. C.; Liotta, L. A. Clinical proteomics: translating benchside promise into bedside reality Nat. Rev. Drug Discov. 2002, 1 (9) 683-695
9. Ludwig, J. A.; Weinstein, J. N. Biomarkers in cancer staging, prognosis and treatment selection Nat. Rev. Cancer 2005, 5, 845-856
10. Chen, C.; Wang, C.; Huang, Y.; Chien, K.; Liang, Y.; Chen, W.; Lin, K. Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance Proteomics 2007, 7, 155-167
11. Cho, H. J.; Baek, K. E.; Park, S.; Kim, I.; Choi, Y.; Cho, H.; Nam, I.; Hwang, E. M.; Park, J.; Han, J. Y.; Kang, S. S.; Kim, D. C.; Lee, W. S.; Lee, M.; Oh, G. T.; Kim, J. W.; Lee, C. W.; Yoo, J. RhoGDI2 Expression Is Associated with Tumor Growth and Malignant Progression of Gastric Cancer Clin. Cancer Res. 2009, 15 (8) 2612-2619
12. Jia, S.; Niu, Z.; Zhang, L.; Zhong, X.; Shi, T.; Du, H.; Zhang, G.; Hu, Y.; Su, X.; Ji, J. Identification of prognosis-related proteins in advanced gastric cancer by mass spectrometry-based comparative proteomics J. Cancer Res. Clin. Oncol. 2009, 135 (3) 403-411
13. He, Q.; Cheung, Y. H.; Leung, S. Y.; Yuen, S. T.; Chu, K.; Chiu, J. Proteomics in biomarker discovery and drug development J. Cell Biochem. 2003, 89 (5) 868-886
14. Takikawa, M.; Akiyama, Y.; Maruyama, K.; Suzuki, A.; Feng, L.; Tai, S.; Ohshita, C.; Kawaguchi, Y.; Bandou, E.; Yonemura, Y.; Yamaguchi, K. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis Oncol. Rep. 2006, 16 (4) 705-711
15. Chen, Y.; Juan, H.; Huang, H.; Huang, H.; Lee, Y.; Liao, M.; Tseng, C.; Lin, L.; Chen, J.; Wang, M.; Chen, J.; Chen, Y. Quantitative Proteomic and Genomic Profiling Reveals Metastasis-Related Protein Expression Patterns in Gastric Cancer Cells J. Proteome Res. 2006, 2727-2742
16. Zheng, H.; Shah, P. K.; Audus, K. L. Evaluation of antiulcer agents with a human adenocarcinoma cell line (AGS) Int. J. Pharm. 1996, 129 (1-2) 103-112
17. John, R.; Masters, W.; Palsson, B., Eds. Human Cell Culture; Kluwer Academic Publishers: Norwell, MA, 1999; Vol. II, pp 257-291.
18. Yu, E. J.; Lee, Y.; Rha, S. Y.; Kim, T. S.; Chung, H. C.; Oh, B. K.; Yang, W. I.; Noh, S. H.; Jeung, H. C. Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma Mol. Cancer Res. 2008, 6 (10) 1554-1566
19. Tan, H. T.; Zubaidah, R. M.; Tan, S.; Hooi, S. C.; Chung, M. C. M. 2-D DIGE Analysis of Butyrate-Treated HCT-116 Cells after Enrichment with Heparin Affinity Chromatography J. Proteome Res. 2006, 5 (5) 1098-1106
20. Sadowski, P. G.; Dunkley, T. P. J.; Shadforth, I. P.; Dupree, P.; Bessant, C.; Griffin, J. L.; Lilley, K. S. Quantitative proteomic approach to study subcellular localization of membrane proteins Nat. Protoc. 2006, 1 (4) 1778-1789
21. Tan, H. T.; Tan, S.; Lin, Q.; Lim, T. K.; Hew, C. L.; Chung, M. C. M. Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells Mol. Cell. Proteomics 2008, 7 (6) 1174-1185
22. Kersey, P. J.; Duarte, J.; Williams, A.; Karavidopoulou, Y.; Birney, E.; Apweiler, R. The International Protein Index: An integrated database for proteomics experiments Proteomics 2004, 4 (7) 1985-1988
23. Marcato, P.; Dean, C. A.; Pan, D.; Araslanova, R.; Gillis, M.; Joshi, M.; Helyer, L.; Pan, L.; Leidal, A.; Gujar, S.; Giacomantonio, C. A.; Lee, P. W. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis Stem Cells 2011, 29, 32-45
24. Zhao, J.; Zhou, Y.; Zhang, Z.; Tian, F.; Ma, N.; Liu, T.; Gu, Z.; Wang, Y. Up-regulated fascin1 in non-small cell lung cancer promotes the migration and invasiveness, but not proliferation Cancer Lett. 2010, 290 (2) 238-247
25. Kim, H. J.; Kim, H. J.; Kim, Y. M.; Lim, S.; Nam, Y. K.; Jeong, J.; Kim, H. J.; Lee, K. J. Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis Oncogene 2009, 28, 117-127
26. Seliger, B.; Fedorushchenko, A.; Brenner, W.; Ackermann, A.; Atkins, D.; Hanash, S.; Lichtenfels, R. Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration Clin. Cancer Res. 2007, 13 (1) 27-37
27. Yoshio, T.; Morita, T.; Kimura, Y.; Tsujii, M.; Hayashi, N.; Sobue, K. Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation FEBS Lett. 2007, 581 (20) 3777-3782
28. Lin, J. J. C.; Li, Y.; Eppinga, R. D.; Wang, Q.; Jin, J. P. Roles of caldesmon in cell motility and actin cytoskeleton remodeling Int. Rev. Cell Mol. Biol. 2009, 274, 1-68
29. Lee, J.; Eom, E.; Kim, D.; Ha-Lee, Y. M.; Lee, D. Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE Genomics 2003, 82 (1) 78-85
30. Köhler, C. Histochemical localization of caldesmon isoforms in colon adenocarcinoma and lymph node metastases Virchows Archiv. 2011, 459 (1) 81-89
31. Zheng, P. P.; van der Weiden, M.; Kros, J. M. Differential expression of Hela-type caldesmon in tumour neovascularization: a new marker of angiogenic endothelial cells J. Pathol. 2005, 205 (3) 408-14
32. Geiger, T.; Madden, S. F.; Gallagher, W. M.; Cox, J.; Mann, M. Proteomic portrait of human breast cancer progression identifies novel prognostic markers Cancer Res. 2012, 72 (9) 2428-2439
33. Hai, C.; Gu, Z. Caldesmon phosphorylation in actin cytoskeletal remodeling Eur. J. Cell Biol. 2006, 85, 305-309
34. Quintavalle, M.; Elia, L.; Price, J. H.; Heynen-Genel, S.; Courtneidge, S. A. A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion Sci. Signal. 2011, 4, 1-9
35. Mukhopadhyay, U. K.; Eves, R.; Jia, L.; Mooney, P.; Mak, A. S. p53 suppresses Src-induced podosome and rosette formation and cellular invasiveness through the upregulation of caldesmon Mol. Cell. Biol. 2009, 29 (11) 3088-3098
36. Morita, T.; Mayanagi, T.; Yoshio, T.; Sobue, K. Changes in the balance between caldesmon regulated by p21-activated kinases and the Arp2/3 complex govern podosome formation J. Biol. Chem. 2007, 282 (11) 8454-8463
37. Leung, W. K. C.; Ching, A. K. K.; Wong, N. Phosphorylation of Caldesmon by PFTAIRE1 kinase promotes actin binding and formation of stress fibers Mol. Cell. Biochem. 2010, 350 (1-2) 201-206
38. Huang, R.; Grabarek, Z.; Wang, C. L. Differential effects of Caldesmon on the intermediate conformational states of polymerizing actin J. Biol. Chem. 2010, 285 (1) 71-79